Roivant Sciences Ltd(ROIV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD

ROIV

Roivant Sciences Ltd

At close September 11 at 2:52 PM ET (Korea 9/12 03:52)

$40.94

-0.87 ▼ -2.08%

Resistance 39.03 Support 34.28 Lines drawn by AI for reference. They may be wrong. Treat them as a hint, not a forecast.

Full metrics table

B-

Fundamental health

vs. 성장주 대형주· based on 3 axes

How profitably the company operates.

산출 불가 (적자)

How fast earnings and revenue are growing.

Top 74%

Whether the stock is cheap or expensive relative to fundamentals.

Top 28%

Whether the company can weather downturns without a heavy debt burden.

Top 29%

💰 Is this stock pricier than usual right now?

Compared to this company's own recent 1Y (not other companies).

💎 Very cheap

Cheap

Typical

Pricey

Very pricey

Simply put. What you pay today to own $1 of this company's yearly earnings is 2 KRW. Over the past 1Y, it usually traded around 2 KRW. One of the cheapest stretches of the past 1Y.

Pricy doesn't mean bad. It means expectations are already baked in.· based on 1 profitable years

Index ⓘ	-	P/E ⓘ	-	EPS (ttm) ⓘ	-0.44	Insider Own ⓘ	27.45%	Shs Outstand ⓘ	722.7M	Perf Week ⓘ	19.78%
Market Cap ⓘ	29.57B	Forward P/E ⓘ	-	EPS next Y ⓘ	4.96%	Insider Trans ⓘ	-3.95%	Shs Float ⓘ	524.1M	Perf Month ⓘ	16.14%
Enterprise Value ⓘ	26.52B	PEG ⓘ	-	EPS next Q ⓘ	-0.37	Inst Own ⓘ	76.44%	Short Float ⓘ	5.84%	Perf Quarter ⓘ	44.1%
Income ⓘ	-0.27B	P/S ⓘ	3927.21	EPS this Y ⓘ	-157.74%	Inst Trans ⓘ	3.88%	Short Ratio ⓘ	4.59	Perf Half Y ⓘ	38.4%
Sales ⓘ	0.01B	P/B ⓘ	6.99	EPS next 5Y ⓘ	10.15%	ROA ⓘ	-5.15%	Short Interest ⓘ	30.60M	Perf YTD ⓘ	88.66%
Book/sh ⓘ	5.86	P/C ⓘ	7.69	EPS past 3/5Y ⓘ	32.67% 34.68%	ROE ⓘ	-6.21%	52W High ⓘ	-3.67% ($42.50)	Perf Year ⓘ	197.31%
Cash/sh ⓘ	5.32	P/FCF ⓘ	-	Sales past 3/5Y ⓘ	-48.73% -19.07%	ROIC ⓘ	-6.15%	52W Low ⓘ	205.64% ($13.40)	Perf 3Y ⓘ	224.92%
Dividend Est. ⓘ	-	EV/EBITDA ⓘ	-	EPS Y/Y TTM ⓘ	45.61%	Gross Margin ⓘ	43.37%	Volatility(W/M) ⓘ	4.87% 3.66%	Perf 5Y ⓘ	311.04%
Dividend TTM ⓘ	-	EV/Sales ⓘ	3522.36	Sales Y/Y TTM ⓘ	-67.58%	Oper. Margin ⓘ	-18146.12%	ATR (14) ⓘ	1.64	Perf 10Y ⓘ	-
Dividend Ex-Date ⓘ	-	Quick Ratio ⓘ	16.72	EPS Q/Q ⓘ	19.77%	Profit Margin ⓘ	-3534.96%	RSI (14) ⓘ	68.31	Recom ⓘ	1.36
Dividend Gr. 3/5Y ⓘ	-	Current Ratio ⓘ	16.72	Sales Q/Q ⓘ	-33.55%	SMA20 ⓘ	11.34% ($36.77)	Beta ⓘ	1.08	Target Price ⓘ	$45.95
Payout ⓘ	-	Debt/Eq ⓘ	0.03	Earnings ⓘ	2026/8/6	SMA50 ⓘ	14.75% ($35.68)	Rel Volume ⓘ	0.98	Prev Close ⓘ	$41.81
Employees ⓘ	721	LT Debt/Eq ⓘ	0.02	EPS/Sales Surpr. ⓘ	-11.72% -29.89%	SMA200 ⓘ	42.13% ($28.8)	Avg Volume(3M) ⓘ	6.67M	Price ⓘ	$40.94
IPO ⓘ	2020/12/8	Option/Short ⓘ	Yes/Yes			Trades ⓘ	46747	Volume ⓘ	6,512,693	Change ⓘ	-2.08%

Company

로이번트 사이언스ROIV | NASD | Biotechnology Details

ROIV is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

🧬 Roivant Sciences (ROIV) is a global biopharmaceutical holding company that develops a diverse portfolio of targeted therapeutics based on its unique "Vant" model. By operating independent disease-specific subsidiaries, it maximizes the speed of new drug candidate development and creates high added value through technology outlicensing and equity sales to pharmaceutical companies.

Quote

Over the past 1 year, on the higher side

4% below its 1-year high.

Day low$40.22Day high$41.40

52w low$13.4052w high$42.50

Open$41.26

Volume6,512,693

Close$40.94

52W Range95%

B+

3 of 8 metrics rate excellent

Is it profitable? C